All Articles

After uniting nine acquired firms under one brand, NowVertical is shifting its focus to organic growth, leveraging integrated operations to exceed targets.

In a landmark deal for Canadian fintech, a federally regulated bank will custody QCAD's reserves, paving the way for institutional stablecoin adoption.

KLAS Research honors uPerform in a new award category, reflecting a critical industry shift where workforce training is now a core strategic priority.

With crucial data on its novel oral inflammation inhibitor looming, NodThera brings in seasoned leader Geoff McDonough to navigate the path to Phase 3.

As AI reshapes jobs, Skillsoft launches its next-gen Percipio platform to help businesses connect learning to measurable skills and workforce readiness.

Aethlon Medical's upcoming Q3 report puts its finances under a microscope as investors weigh a tight cash runway against progress on its Hemopurifier device.

With new revenue and client success chiefs, Gozio Health signals an aggressive push to scale its mobile platform and deliver tangible ROI to health systems.

A new biotech partnership is accelerating development of a once-daily tablet for hypoparathyroidism, a rare disease currently requiring injections.

Thousands, including minors, were secretly filmed in Northwell Health bathrooms. A new lawsuit exposes the breach and a year-long notification delay.

A powerful new genomic tool is turning genetic doubt into diagnostic certainty, helping thousands of patients understand their true hereditary cancer risk.

Aramark has increased its quarterly dividend, a move reflecting strong financials. But what does it say about its strategy in a changing global market?

Six months in, SK Telecom's Haein GPU cluster is more than a service; it's the national infrastructure engine driving South Korea's AI sovereignty.

Engineering firm Jacobs to design one of the world's largest storm surge barriers, a multibillion-dollar bet to save the Texas Gulf Coast from disaster.

A new poll for America's 250th birthday shows a nation that reveres its Founders but has abandoned their core beliefs on rights and government.

With a 90% clinical trial failure rate, BullFrog AI is launching a new tool to help drugmakers make smarter, risk-balanced R&D decisions.

With key data on its Duchenne muscular dystrophy drugs expected in 2026, Entrada's CEO Dipal Doshi will detail the firm's high-risk, high-reward strategy.

Superior Health's acquisition of Pulse Home Health, backed by private equity, signals a major shift in Louisiana's booming home health and hospice market.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

Nataly M. Marks, President of Triple-S Steel, joins the MSC Income Fund board, bringing deep operational and financial expertise to its investment strategy.

Dragonfly Energy's new power pack won two major sustainability awards. The tech cuts truck idling by 70%, saving fleets fuel and slashing emissions.